1-6 of 6
Keywords: α-Interferon
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal: Dermatology
Dermatology (1995) 190 (4): 324–326.
Published Online: 07 October 2009
...L. Bossuyt; J.J. Van den Oord; H. Degreef An HIV-positive black man developed subcutaneous noduli in the framework of a lymphangioma-like variant of Kaposi’s sarcoma. Extensive lymphedema formation also occurred on the legs, face and hands. Treatment with α-interferon led to partial regression...
Journal Articles
Journal: Dermatology
Dermatology (1996) 193 (2): 100–104.
Published Online: 06 October 2009
... the immunosuppressive treatment, in association with α-interferon or vindesine in 2 cases, respectively. All patients were alive after a follow-up of 19-45 months. Conclusion: KS seems relatively frequent (2%) and appears within a short delay after liver transplantation; the prognosis may be more favourable than...
Journal Articles
Journal Articles
Journal: Dermatology
Dermatology (2004) 208 (1): 49–54.
Published Online: 03 February 2004
...B. Guillot; L. Blazquez; D. Bessis; O. Dereure; J.J. Guilhou Introduction: α-Interferon is associated with numerous cutaneous side effects, but the accurate incidence of these complications is not clearly known. Objectives: A prospective study was designed to evaluate the incidence and clinical...
Journal Articles
Journal: Dermatology
Dermatology (2004) 208 (1): 43–48.
Published Online: 03 February 2004
...Delphine Pirard; Michel Heenen; Christian Melot; Pierre Vereecken Background: The literature on the benefit of α-interferon (IFN-α) as adjuvant postsurgical treatment of melanoma reports discordant results. Objective: With the published data so far, we performed a meta-analysis in order to evaluate...
Journal Articles
Journal: Dermatology
Dermatology (2003) 207 (1): 116–118.
Published Online: 18 July 2003
...Reinhard Dummer; Mirjana Urosevic; Werner Kempf; Dmitry Kazakov; Günter Burg Imiquimod is a topical immune response modifier that binds to Toll-like receptors 7 and 8 and induces α-interferon. We locally applied imiquimod 5% cream (Aldara ® ) daily for 2 weeks on a PUVA- and retinoid-resistant...